Abstract
Purpose. To assess the significance of S-phase fraction (SPF) and DNA ploidy evaluated by DNA flow cytometry as prognostic markers in stage I or II breast cancer.
Patients and methods. A series of 271 patients, treated by surgery, radiotherapy ± systemic therapy was analyzed (median follow up: 64 months). Standardized flow cytometry cell preparation from frozen samples and consensus rules for data interpretation were followed. Three SPF classes were defined on the basis of tertiles after adjustment for ploidy. Four groups were defined based on combinations of DNA ploidy (DIP: diploid; ANEUP: aneuploid) and SPF: DIP and low SPF (DL, n=37), DIP and medium or high SPF (DMH, n=76), ANEUP and low SPF (AL, n=24), ANEUP and medium or high SPF (AMH, n=68). Local control rate (LCR), disease-free survival (DFS), metastasis-free survival (MFS), and overall survival (OS) were correlated with DNA ploidy, SPF, DL to AMH groups, T and N stages, SBR grading, age, and hormonal status on univariate and multivariate analysis (Cox model).
Results. On univariate analysis, DFS and LCR were higher for DIP tumours. High SPF values were associated with shorter DFS. LCR, MFS, DFS, and OS rates were significantly different with an increasingly poorer prognosis from DL to AMH. On multivariate analysis, groups DL to AMH, histological node involvement and T stage were independently associated with MFS, and DFS. In N(−) patients, DL to AMH remained independent for MFS and DFS. For SBR III tumours, MFS and OS were significantly different in DL to AMH groups. These results strongly support the use of combined evaluation of DNA ploidy and SPF as independent parameters in clinical trials for N(−) stage I and II breast cancer.
Similar content being viewed by others
Abbreviations
- AL:
-
aneuploid tumours with low SPF values
- AMH:
-
aneuploid tumours with intermediate or high SPF values
- DL:
-
diploid tumours with low SPF values
- DMH:
-
diploid tumours with intermediate or high SPF values
References
RS Camplejohn CM Ash CE Gillett B Raikundalia DM Barnes WM Gregory MA Richards RR. Millis (1995) ArticleTitleThe prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre Br J Cancer 71 140–145 Occurrence Handle1:STN:280:ByqC3MfnvVI%3D Occurrence Handle7819030
TE Kute Y Quadri H Muss N Zbieranski C Cirrincione DA Berry M Barcos AP Thor E Liu F. Koerner (1995) ArticleTitleFlow cytometry in node-positive breast cancer: cancer and leukemia group B protocol 8869 Cytometry 22 297–306 Occurrence Handle1:STN:280:BymA2MnjvVM%3D Occurrence Handle8749780
J Bryant B Fisher N Gunduz J Costantino B. Emir (1998) ArticleTitleS-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen-receptor-positive breast cancer Breast Cancer Res Treat 51 239–253 Occurrence Handle10.1023/A:1006184428857 Occurrence Handle1:STN:280:DyaK1M7msFCmsw%3D%3D Occurrence Handle10068082
GM Clark MC Mathieu MA Owens LG Dressler L Eudey DC Tormey CK Osborne KW Gilchrist EG Mansour MD. Abeloff (1992) ArticleTitlePrognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients J Clin Oncol 10 428–432 Occurrence Handle1:STN:280:By2C2MnoslU%3D Occurrence Handle1740681
P Dettmar N Harbeck C Thomssen L Pache P Ziffer K Fizi F Janicke W Nathrath M Schmitt H Graeff H. Hofler (1997) ArticleTitlePrognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer Br J Cancer 75 1525–1533 Occurrence Handle1:STN:280:ByiA3cbltlA%3D Occurrence Handle9166949
SM O’Reilly RS Camplejohn DM Barnes RR Millis RD Rubens MA. Richards (1990) ArticleTitleNode-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry J Clin Oncol 8 2040–2046 Occurrence Handle1:STN:280:By6D3sfitVE%3D Occurrence Handle2230896
R Silvestrini MG Daidone A Luisi M Mastore M Leutner B. Salvadori (1997) ArticleTitleCell proliferation in 3,800 node-negative breast cancers: consistency over time of biological and clinical information provided by 3H-thymidine labelling index Int J Cancer 74 122–127 Occurrence Handle10.1002/(SICI)1097-0215(19970220)74:1<122::AID-IJC20>3.0.CO;2-G Occurrence Handle1:STN:280:ByiC1cfivFE%3D Occurrence Handle9036880
P Rudolph P Alm HJ Heidebrecht H Bolte V Ratjen B Baldetorp M Ferno H Olsson R. Parwaresch (1999) ArticleTitleImmunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer J Natl Cancer Inst 91 271–278 Occurrence Handle10.1093/jnci/91.3.271 Occurrence Handle1:STN:280:DyaK1M7lsVOisg%3D%3D Occurrence Handle10037106
S Chevillard J Lebeau P Pouillart C Toma Particlede C Beldjord B Asselain J Klijanienko A Fourquet H Magdelenat P. Vielh (1997) ArticleTitleBiological and clinical significance of concurrent p53 gene alterations, MDR1 gene expression, and S-phase fraction analyses in breast cancer patients treated with primary chemotherapy or radiotherapy Clin Cancer Res 3 2471–2478 Occurrence Handle1:CAS:528:DyaK1cXisFSjsg%3D%3D Occurrence Handle9815649
F Spyratos M Briffod M Tubiana-Hulin C Andrieu C Mayras C Pallud S Lasry J. Rouesse (1992) ArticleTitleSequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. II. DNA flow cytometry changes during chemotherapy, tumor regression, and short-term follow-up Cancer 69 470–475 Occurrence Handle1:STN:280:By2D1MnpvVA%3D Occurrence Handle1728376
O Stal L Skoog LE Rutqvist JM Carstensen S Wingren S Sullivan AC Andersson M Dufmats B. Nordenskjold (1994) ArticleTitleS-phase fraction and survival benefit from adjuvant chemotherapy or radiotherapy of breast cancer Br J Cancer 70 1258–1262 Occurrence Handle1:STN:280:ByqD2s7osl0%3D Occurrence Handle7981085
AD Thor S Liu DH Moore SM. Edgerton (1999) ArticleTitleComparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer J Clin Oncol 17 470–477 Occurrence Handle1:STN:280:DyaK1M7nvVKksA%3D%3D Occurrence Handle10080587
S Romain IJ Christensen O Chinot I Balslev C Rose PM Martin SM. Thorpe (1995) ArticleTitlePrognostic value of cytosolic thymidine kinase activity as a marker of proliferation in breast cancer Int J Cancer 61 7–12 Occurrence Handle1:STN:280:ByqB387gtlc%3D Occurrence Handle7705935
F Spyratos PM Martin K Hacene S Romain C Andrieu M Ferrero-Pous S Deytieux V Le Doussal M Tubiana-Hulin M. Brunet (1992) ArticleTitleMultiparametric prognostic evaluation of biological factors in primary breast cancer J Natl Cancer Inst 84 1266–1272 Occurrence Handle1:STN:280:By2A2cbksF0%3D Occurrence Handle1640487
D Amadori R. Silvestrini (1998) ArticleTitleand predictive value of thymidine labelling index in breast cancer Breast Cancer Res Treat 51 267–281 Occurrence Handle10.1023/A:1006140629766 Occurrence Handle1:STN:280:DyaK1M7msFCmsQ%3D%3D Occurrence Handle10068084
B Dutrillaux M Gerbault-Seureau Y Remvikos B Zafrani M. Prieur (1991) ArticleTitleBreast cancer genetic evolution. I. Data from cytogenetics and DNA content Breast Cancer Res Treat 19 245–255 Occurrence Handle1:STN:280:By2C3srosFM%3D Occurrence Handle1663804
Anonymous (1996) ArticleTitleClinical practice guidelines for the use of tumor markers in breast and colorectal cancer Adopted on May,1996 by the American Society of Clinical Oncology J Clin Oncol 17 IssueID14 2843–2877
F Duigou P Herlin J Marnay JJ. Michels (2000) ArticleTitleVariation of flow cytometric DNA measurement in 1,485 primary breast carcinomas according to guidelines for DNA histogram interpretation Cytometry 42 35–42 Occurrence Handle10.1002/(SICI)1097-0320(20000215)42:1<35::AID-CYTO6>3.0.CO;2-J Occurrence Handle1:CAS:528:DC%2BD3cXhvFaku7c%3D Occurrence Handle10679741
SB Ewers R Attewell B Baldetorp A Borg E Langstrom D. Killander (1992) ArticleTitlePrognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas Breast Cancer Res Treat 20 93–108 Occurrence Handle1:STN:280:By2B3cfivVM%3D Occurrence Handle1554892
MF Gnant GH Blijham A Reiner M Schemper M Reynders B Schutte C Asche Particlevan G Steger R. Jakesz (1992) ArticleTitleDNA ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer: 10 year results of a randomised study Eur J Cancer 28 711–716 Occurrence Handle1:STN:280:By2B2szjsFw%3D Occurrence Handle1591097
OP Kallioniemi G Blanco M Alavaikko T Hietanen J Mattila K Lauslahti M Lehtinen T. Koivula (1988) ArticleTitleImproving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction A proposed classification of DNA histograms in breast cancer Cancer 61 2183–2190 Occurrence Handle2452681
SM O’Reilly RS Camplejohn DM Barnes RR Millis D Allen RD Rubens MA. Richards (1990) ArticleTitleDNA index, S-phase fraction, histological grade and prognosis in breast cancer Br J Cancer 61 671–674 Occurrence Handle1:STN:280:By%2BB2cfitlw%3D Occurrence Handle2159768
Y Remvikos V Mosseri B Asselain A Fourquet JC Durand P Pouillart H. Magdelenat (1997) ArticleTitleS-phase fractions of breast cancer predict overall and post-relapse survival Eur J Cancer 33 581–586 Occurrence Handle10.1016/S0959-8049(96)00531-X Occurrence Handle1:STN:280:ByiH3MbptlY%3D Occurrence Handle9274438
TV Shankey PS Rabinovitch B Bagwell KD Bauer RE Duque DW Hedley BH Mayall L Wheeless C. Cox (1993) ArticleTitleGuidelines for implementation of clinical DNA cytometry Cytometry 14 472–477 Occurrence Handle1:STN:280:ByyA2MfmvFA%3D Occurrence Handle8354117
CR Wenger GM. Clark (1998) ArticleTitleS-phase fraction and breast cancer: a decade of experience Breast Cancer Res Treat 51 255–265 Occurrence Handle10.1023/A:1006188512927 Occurrence Handle1:STN:280:DyaK1M7msFCmsA%3D%3D Occurrence Handle10068083
Anonymous (1998) ArticleTitle1997 update of recommendations for the use of tumor markers in breast and colorectal cancer Adopted on November 7, 1997 by the American Society of Clinical Oncology J Clin Oncol 16 793–795 Occurrence Handle9469371
A Chassevent ML Jourdan M Ferrero-Pous M Colonna S Romain F Spyratos H Roth M. Bolla (1999) ArticleTitleStandardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study. II. DNA-ploidy and S-phase fraction Bull Cancer 86 685–691 Occurrence Handle1:STN:280:DyaK1Mvgs1Cmuw%3D%3D Occurrence Handle10477386
A Chassevent ML Jourdan S Romain F Descotes M Colonna PM Martin M Bolla F Spyratos PHRC95 forMulticenterStudy Group (2001) ArticleTitleS-Phase Fraction and DNA Ploidy in 633 T1T2 Breast Cancers A Standardized Flow Cytometric Study Clin Cancer Res 7 909–917 Occurrence Handle1:CAS:528:DC%2BD3MXjs1elsLc%3D Occurrence Handle11309341
ES Kaplan P. Meier (1958) ArticleTitleNon-parametric estimation from incomplete observations Am Stat Assoc J 53 457–480
DR. Cox (1972) ArticleTitleRegression models and life tables J R Stat Soc B 34 187–220
R Charlotte CR Wenger GM. Clark (1998) ArticleTitleS-phase fraction and breast cancer – a decade of experience Breast Cancer Res Treat 51 255–265 Occurrence Handle10.1023/A:1006188512927 Occurrence Handle1:STN:280:DyaK1M7msFCmsA%3D%3D Occurrence Handle10068083
R Largillier M Namer A Ramaioli JM Ferrero N Magne A Courdi P Leblanc-Talent P Formento F Ettore G. Milano (2003) ArticleTitlePrognostic value of S-phase fraction in 920 breast cancer patients: focus on T1N0 status Int J Biol Markers 18 273–279 Occurrence Handle1:STN:280:DC%2BD2c%2FlsFarsw%3D%3D Occurrence Handle14756542
JJ Michels J Marnay T Delozier Y Denoux J. Chasle (2004) ArticleTitleProliferative activity in primary breast carcinomas is a salient prognostic factor Cancer 100 455–464 Occurrence Handle10.1002/cncr.11916 Occurrence Handle14745860
JF Simpson R Gray LG Dressler CD Cobau CI Falkson KW Gilchrist KJ Pandya DL Page NJ. Robert (2000) ArticleTitlePrognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189 J Clin Oncol 18 2059–2069 Occurrence Handle1:STN:280:DC%2BD3c3ntF2qtw%3D%3D Occurrence Handle10811671
A Goldhirsch JH Glick RD Gelber HJ. Senn (1998) ArticleTitleMeeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer J Natl Cancer Inst 90 1601–1608 Occurrence Handle10.1093/jnci/90.21.1601 Occurrence Handle1:STN:280:DyaK1M%2FislCnug%3D%3D Occurrence Handle9811309
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moureau-Zabotto, L., Bouchet, C., Cesari, D. et al. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer. Breast Cancer Res Treat 91, 61–71 (2005). https://doi.org/10.1007/s10549-004-7047-1
Issue Date:
DOI: https://doi.org/10.1007/s10549-004-7047-1